Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : TLT.v -- Ignore unavailable to you. Want to Upgrade?

To: 3bar who wrote (1261)	4/25/2019 8:11:42 PM
From: ogi	1 Recommendation Recommended By 3bar Read Replies (1) \| Respond to of 1869

Not paranoid. Well aware TLT has been shorted to death, not by pharma companies either. Meanwhile, think about the world of oncology companies, do you really think they are all united in an effort to defeat a new and powerful treatment/cure? I don't think so. If I were a cancer pharma ceo I would want to buy a position in a new revolutionary cure/treatment for cancer that could promise many billions in revenue over a couple of decades. But I could not commit serious cash until the numbers were demonstrated to be reliable and repeatable, otherwise I would be open to irresponsible use of funds. TLT is very close to attracting such a deal. I look forward to it, once TLT has the imprimatur of a major pharma player the short will dry up and TLT will surge. I admit, a smaller cautious deal, with an ability to lever up later might be appropriate right now, perhaps the new CEO can attract that, otherwise it is another PP. Time to get moving on both phase 2 and on brain cancer. Phase 2 Toronto a good start but we need locations in the U.S..A. and that will also mean more cash than TLT currently has. All in all we are doing far better than we were. for that I am Thankful